[Liver in progressive myoclonus epilepsy (Lafora's disease) (author's transl)].
D001921:Brain / Q000473:pathology; D003593:Cytoplasm / Q000032:analysis; D004827:Epilepsy / Q000473:pathology*; D006008:Glycogen Storage Disease / Q000473:pathology; D006025:Glycosaminoglycans / Q000378:metabolism; D006505:Hepatitis / Q000209:etiology; D006651:Histocytochemistry; D006801:Humans; D002479:Inclusion Bodies; D007728:Kupffer Cells / Q000032:analysis; D008099:Liver / Q000032:analysis / Q000166:cytology / Q000378:metabolism / Q000473:pathology*; D008661:Metabolism, Inborn Errors / Q000473:pathology; D009132:Muscles / Q000473:pathology; D009206:Myocardium / Q000473:pathology; D009207:Myoclonus / Q000473:pathology*; D013577:Syndrome
D006025:Glycosaminoglycans
Die Leber bei der progressiven Myoklonusepilepsie (Lafora's disease)